Dear Colleagues,
It is our great pleasure to welcome you to the Lymphoma 2022 Virtual Conference: State-of-the-Art and Future Directions which will take place February 24th, 2022.
The aims of this conference are to present a state-of-the-art update on etiology and genomics of lymphoma, to discuss novel therapies recently approved or currently evaluated for lymphoma treatments and to summarize the current knowledge and future directions in treatment of most common lymphomas. The lectures will be presented by international lymphoma experts.
We look forward to seeing you at Lymphoma 2022 Virtual Conference: State-of-the-Art and Future Directions.
Sincerely,
Izidore S. Lossos M.D.
Conference Chair
Sponsors
All Sponsors
Meet our Speakers
University of Rochester Cancer Center, NY, USA
Memorial Sloan Kettering Cancer Center, NY, USA
Washington University, MO, USA
Memorial Sloan Kettering Cancer Center, NY, USA
Memorial Sloan Kettering Cancer Center, NY, USA
Conference Program
University of Rochester Cancer Center, NY, USA
Saint Louis Hospital, France
Memorial Sloan Kettering Cancer Center, NY, USA
Tel Aviv Sourasky Medical Center, Israel
University of Miami, FL, USA
Memorial Sloan Kettering Cancer Center, NY, USA
Rigshospitalet, Copenhagen University Hospital, Denmark
Washington University, MO, USA
MD Anderson Cancer Center, TX, USA
MD Anderson Cancer Center, TX, USA
Sylvester Comprehensive Cancer Center, University of Miami, FL
Alpert Medical School of Brown University, RI,USA
University of California, CA, USA
Memorial Sloan Kettering Cancer Center, NY, USA
Mayo Clinic, MN, USA
Duke Cancer Institute, NC, USA
Mayo Clinic, MN, USA
Stanford University, CA, USA
Contact Us
We look forward to hearing from you.